TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
XBIT

XBiotech Inc

Healthcare · Biotechnology

2.20$ -0.5% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet XBIT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
93.4% 85.1% 55.1% 52.9% 38.4% 87.7% 92.1% 89.7% 89.3% 89.0% 87.7% 84.6%
92.2% 83.3% 51.2% 50.4% 35.7% 87.5% 67.1% 86.1% 63.9% 88.3% 86.7% 83.7%
92.2% 83.3% 51.2% 50.4% 35.7% 87.5% 67.1% 86.1% 88.4% 88.3% 86.7% 83.7%
0.0% 1.2% 3.3% 0.7% 0.4% 0.4% 0.2%
0.0% 0.0% 0.0% -1.9% -3.3%
6.6% 5.4% 15.1% 47.1% 61.6% 3.1% 7.7% 10.3% 10.7%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
5.1% 5.8% 11.9% 4.5% 6.6% 7.5% 1.4% 2.1% 2.3% 3.4% 8.5% 6.5%
5.1% 5.8% 11.9% 4.4% 6.6% 7.4% 1.1% 1.3% 1.7% 2.7% 7.6% 5.3%
5.1%
2.6% 4.4% 6.6% 2.7% 3.7% 0.3% 0.7% 0.8% 1.0% 1.1% 1.1% 1.0%
0.0% 0.0% 0.0%
94.9% 94.2% 88.1% 95.5% 93.4% 92.5% 98.6% 97.9% 97.7% 96.6% 91.5% 93.5%
-149.8% -119.5% -273.5% -343.9% -536.0% 52.8% 27.6% 1.9% -11.3% -23.1% -45.6% -90.9%
51.0% 28.2% 48.3% 55.4% 80.7% 5.7% 8.7% 10.9% 12.4% 13.4% 15.3% 20.3%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?